Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melonoma
Abstract
A compound for use as a diagnostic or therapeutic pharmaceutical and method of using the same where the compound consists essentially of an alpha-melanotropin stimulating hormone analog which has integrally located a radionuclide. The radionuclide is administered to the body in an amount sufficient to allow uptake and retention by the tumor cells.
- Inventors:
- Issue Date:
- Research Org.:
- Univ. of Missouri, Columbia, MO (United States)
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1531460
- Patent Number(s):
- 6607709
- Application Number:
- 09/686,700
- Assignee:
- The Curators of the University of Missouri (Columbia, MO)
- Patent Classifications (CPCs):
-
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- DOE Contract Number:
- FG02-93ER61661
- Resource Type:
- Patent
- Resource Relation:
- Patent File Date: 2000-10-11
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 62 RADIOLOGY AND NUCLEAR MEDICINE
Citation Formats
Jurisson, Silvia S., Quinn, Thomas P., and Giblin, Michael F. Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melonoma. United States: N. p., 2003.
Web.
Jurisson, Silvia S., Quinn, Thomas P., & Giblin, Michael F. Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melonoma. United States.
Jurisson, Silvia S., Quinn, Thomas P., and Giblin, Michael F. Tue .
"Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melonoma". United States. https://www.osti.gov/servlets/purl/1531460.
@article{osti_1531460,
title = {Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melonoma},
author = {Jurisson, Silvia S. and Quinn, Thomas P. and Giblin, Michael F.},
abstractNote = {A compound for use as a diagnostic or therapeutic pharmaceutical and method of using the same where the compound consists essentially of an alpha-melanotropin stimulating hormone analog which has integrally located a radionuclide. The radionuclide is administered to the body in an amount sufficient to allow uptake and retention by the tumor cells.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2003},
month = {8}
}
Save to My Library
You must Sign In or Create an Account in order to save documents to your library.